Protocatechuic acid inhibits proliferation, migration and inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes.

In conclusion, the results indicated that PCA exhibited an inhibitory effect on RA-FLSs via inhibiting the NF-κB and Akt/mTOR signalling pathways. These findings supported the concept that PCA might be a therapeutic agent for RA treatment. PMID: 32510258 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32510258?dopt=Abstract

Source: Artificial Cells, Nanomedicine and Biotechnology - June 9, 2020 Category: Biotechnology Tags: Artif Cells Nanomed Biotechnol Source Type: research